Josh Mandel-Brehm
Chief Executive Officer, Director · Camp4 Therapeutics Corp
- 2024
- Aug 5, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Josh Mandel-Brehm files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- 5AM Partners VI, LLC - $4.86M in CAMP purchases and sales in the last 12 months
- Andrew J. Schwab - $2.50M in CAMP purchases and sales in the last 12 months
- Kelly Gold - $50K in CAMP purchases and sales in the last 12 months
- Richard A. Young - $27K in CAMP purchases and sales in the last 12 months
- Yuri Maricich - $11K in CAMP purchases and sales in the last 12 months
- Daniel Tardiff - $8K in CAMP purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Josh Mandel-Brehm?
Josh Mandel-Brehm is a corporate insider, tracked as Chief Executive Officer, Director of Camp4 Therapeutics Corp (CAMP). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Josh Mandel-Brehm submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Josh Mandel-Brehm been buying or selling stock?
Recorded transactions: 2 open-market purchases ($21K) and 0 open-market sales across all tracked filings.
